The program will provide eligible patients with an imaging test and a biomarker test that measures the immune system’s response to diseases in the blood, according to an April 6 news release.
Biomarker testing looks for genes, proteins and other substances to provide information about cancer.
“Pancreas cancer is predicted to become the second-leading cause of cancer death in the world by 2030, overtaking colon cancer,” Rosario Ligresti, MD, chief of gastroenterology at Hackensack University Medical Center, said in the release. “We absolutely need a better way to screen for it.”
The center will provide screenings from April 1 to Sept. 30 between 9 a.m. and 12 p.m.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
